Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Weinberg

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Carcinogenesis|October 28, 2003
RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase propertiesElizabeth J Horn, Amador Albor, Yuangang Liu, et al.
Genes & Development|July 15, 1997
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiationB Andersen, W C Weinberg, O Rennekampff, et al.
Cancer Research|September 22, 2011
TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancerHai Lu, Xinping Yang, Praveen Duggal, et al.
Urology Practice|August 18, 2023
Use of Partial Nephrectomy after Acquisition of a Surgical Robot: A Population Based StudyAaron C Weinberg, Jason D Wright, Michael J Whalen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 1996
Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53K Forrester, S Ambs, S E Lupold, et al.
Frontiers in Immunology|August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesisNozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
Molecular and Cellular Biology|May 9, 2002
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53Ester Fernández-Salas, Kwang S Suh, Vladislav V Speransky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancerGideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Carcinogenesis|October 28, 2003
RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase propertiesElizabeth J Horn, Amador Albor, Yuangang Liu, et al.
Genes & Development|July 15, 1997
Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiationB Andersen, W C Weinberg, O Rennekampff, et al.
Cancer Research|September 22, 2011
TNF-α promotes c-REL/ΔNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancerHai Lu, Xinping Yang, Praveen Duggal, et al.
Urology Practice|August 18, 2023
Use of Partial Nephrectomy after Acquisition of a Surgical Robot: A Population Based StudyAaron C Weinberg, Jason D Wright, Michael J Whalen, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 1996
Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53K Forrester, S Ambs, S E Lupold, et al.
Frontiers in Immunology|August 28, 2023
Oncogenic Ras and ΔNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesisNozomi Sakakibara, Paúl E Clavijo, Cem Sievers, et al.
Molecular and Cellular Biology|May 9, 2002
mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53Ester Fernández-Salas, Kwang S Suh, Vladislav V Speransky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2013
First FDA approval of dual anti-HER2 regimen: pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancerGideon M Blumenthal, Nancy S Scher, Patricia Cortazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 2014
FDA approval: ado-trastuzumab emtansine for the treatment of patients with HER2-positive metastatic breast cancerLaleh Amiri-Kordestani, Gideon M Blumenthal, Qiang Casey Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 17, 2021
FDA Approval Summary: Margetuximab plus Chemotherapy for Advanced or Metastatic HER2-Positive Breast CancerMelanie Royce, Christy L Osgood, Anup K Amatya, et al.
Pageof 15